Fig. 4From: A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients111In-OTSA-101 SPECT-CT images performed at H72 in patient 3 showing a grade 2 lesion in the right lower lung lobe (a) and a grade 4 lesion in the left lower lung lobe (b)Back to article page